Prof. Dr. G. Schett

Publications: Prof. Dr. med. univ. G. Schett

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium , Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I: Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus. Ann Rheum Dis. 2026;85(1): 153-163
Tur C, Eckstein M, Rauber S, Schett G, Bozec A, Raimondo MG: Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'. Ann Rheum Dis. 2026;85(1): e1-e2
Garantziotis P, Auth J, Schett G, Bergmann C: CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation. Curr Opin Rheumatol. 2026;38(1): 60-68
Rizzo C, Coronel L, De Lorenzis E, Rubortone P, Möller I, Miguel Perez M, Tur C, Raimondo MG, Belmonte B, Cancila V, Ramming A, Schett G, Lizzio MM, Alivernini S, Guggino G, D'Agostino MA: Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique. RMD Open. 2025;11(2):
Dreiner M, Godonou ET, Mündermann A, Tascilar K, Schett G, Zaucke F, Liphardt AM, Niehoff A: Immobilization by 21-days of bed rest causes changes in biomarkers of cartilage homeostasis in healthy individuals. Osteoarthr Cartil Open. 2025;7(2):
Jakobi S, Boy K, Wagner M, May S, Temiz A, Liphardt AM, Araujo E, Carmona L, Knevel R, Schett G, Knitza J, Muehlensiepen F, Morf H: Rheumatic? A diagnostic decision support tool for individuals suspecting rheumatic diseases: Mixed-methods usability and acceptability study. BMC Rheumatol. 2025;9(1):
Ringer M, Maccataio A, Zapf R, Gaculenko A, Adam S, Aust O, Loskarn S, Luther J, Aksoy B, Popp V, Weidner D, Eck M, Munoz L, Bozec A, Uderhardt S, Bäuerle T, Schett G, Krönke G, Hüffmeier U, Frey S, Steffen U: Loss of myeloperoxidase aggravates skin and joint inflammation in the mannan-induced psoriatic arthritis mouse model. J Leukoc Biol. 2025;117(9):
Weishaupt K, Ackermann J, Burger P, Chambers D, Grimm K, Weinkam R, Correa Zamora A, Auger JP, Frey B, Schett G, Krönke G: Individual subsets of alternatively-activated macrophages differentially contribute to tissue repair and the resolution of inflammation. J Immunol. 2025;214(12): 3554-3564
Kemenes S, Chang L, Schlereth M, Noversa de Sousa R, Minopoulou I, Fenzl P, Corte G, Yalcin Mutlu M, Höner MW, Sagonas I, Coppers B, Liphardt AM, Simon D, Kleyer A, Folle L, Sticherling M, Schett G, Maier A, Fagni F: Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index. Front Med (Lausanne). 2025;12():
Kemenes S, Chang L, Schlereth M, Noversa de Sousa R, Minopoulou I, Fenzl P, Corte G, Yalcin Mutlu M, Höner MW, Sagonas I, Coppers B, Liphart AM, Simon D, Kleyer A, Folle L, Sticherling M, Schett G, Maier A, Fagni F: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index. Front Med (Lausanne). 2025;12():
Hagen M, Müller F, Wirsching A, Kharboutli S, Spoerl S, Düsing C, Krickau T, Metzler M, Völkl S, Aigner M, Kretschmann S, Vasova I, Saake M, Schliep S, Kubacki T, Hunzelmann N, Bucci L, Taubmann J, Bergmann C, Györfi AH, Dietrich S, Distler JHW, Grieshaber-Bouyer R, Mackensen A, Schett G: Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' reply. Lancet Rheumatol.. 2025;7(10): e667-e669
Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, Bucci L, Zhang L, Kretschmann S, Aigner M, Eckstein M, Spörl S, Kharboutli S, Böltz S, Atzinger A, Munoz L, Schett G, Mackensen A, Grieshaber-Bouyer R: BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells. Nat Med. 2025;31(6): 1793-1797
Ostendorf L, Garantziotis P, Huang FY, Schett G, Accelerating Medicines Partnership: RA/SLE Network , Lederer JA, Fava A, Rao DA, Grieshaber-Bouyer R: Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis. Eur J Immunol. 2025;55(8):
Hagen M, Müller F, Wirsching A, Kharboutli S, Spoerl S, Düsing C, Krickau T, Metzler M, Völkl S, Aigner M, Kretschmann S, Vasova I, Saake M, Schliep S, Kubacki T, Hunzelmann N, Bucci L, Taubmann J, Bergmann C, Györfi AH, Dietrich S, Distler JHW, Grieshaber-Bouyer R, Mackensen A, Schett G: Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study. Lancet Rheumatol.. 2025;7(6): e424-e433
Tur C, Eckstein M, Schett G, Raimondo MG: Response to the correspondence on "CD19-CAR T-cell therapy induces deep tissue depletion of B cells". Ann Rheum Dis. 2025;84(8): e38-e39
Port H, Coppers B, Tragl S, Manger E, Niemiec LM, Bayat S, Simon D, Fagni F, Corte G, Bay-Jensen AC, Tascilar K, Hueber AJ, Schmidt KG, Schönau V, Sticherling M, Heinrich S, Leyendecker S, Bohr D, Schett G, Kleyer A, Holm Nielsen S, Liphardt AM: Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function. Sci Rep. 2025;15(1):
Biermann MHC, Podolska MJ, Knopf J, Reinwald C, Weidner D, Maueröder C, Hahn J, Kienhöfer D, Barras A, Boukherroub R, Szunerits S, Bilyy R, Hoffmann M, Zhao Y, Schett G, Herrmann M, Munoz LE: Corrigendum: Oxidative burst-dependent NETosis is implicated in the resolution of necrosis-associated sterile inflammation. Front Immunol. 2025;16():
Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, Weber S, Angeli MR, Raimondo MG, Chang J, Huang K, Distler JHW, Distler O, Rauber S, Schett G, Ramming A, Ramming AM: Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Ann Rheum Dis. 2025;84(11): 1865-1876
Atzinger A, Tascilar K, Kleyer A, Hueber AJ, Schmidkonz C, Kuwert T, Beck M, Fagni F, Corte G, Ramming A, Schett G, Bayat S: Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease. RMD Open. 2025;11(4):
Witte T, Minopoulou I, Drzeniek NM, Torgutalp M, Sabat R, Casteleyn V, Albach F, Fagni F, Schett G, Zabotti A, Krönke G, McGonagle D, Köhm M, Behrens F, Kleyer A, Simon D: Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease. Autoimmun Rev. 2025;24(8):
Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, Burkhardt H, Capon F, Chung R, Curtis CJ, Duckworth M, Ellinghaus E, FitzGerald O, Gerdes S, Griffiths CEM, Gulliver S, Helliwell PS, Ho P, Hoffmann P, Holmen OL, Huang ZM, Hveem K, Jadon D, Köhm M, Kraus C, Lamacchia C, Lee SH, Ma F, Mahil SK, McHugh N, McManus R, Modalsli EH, Nissen MJ, Nöthen M, Oji V, Oksenberg JR, Patrick MT, Perez White BE, Ramming A, Rech J, Rosen C, Sarkar MK, Schett G, Schmidt B, Tejasvi T, Traupe H, Voorhees JJ, Wacker EM, Warren RB, Wasikowski R, Weidinger S, Wen X, Zhang Z, BSTOP study group , Estonian Biobank research team , Barton A, Chandran V, Esko T, Foerster J, Franke A, Gladman DD, Gudjonsson JE, Gulliver W, Hüffmeier U, Kingo K, Kõks S, Liao W, Løset M, Mägi R, Nair RP, Rahman P, Reis A, Smith CH, Di Meglio P, Barker JN, Tsoi LC, Simpson MA, Elder JT, Burden AD, Smith CH, Brown SJ, Dand N, Mahil SK, McAteer H, Schofield J, Siebert S, Metspalu A, Milani L, Nelis M: GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Nat Commun. 2025;16(1):
Garantziotis P, Nikolopoulos D, Katechis S, Temiz A, Nöthling DM, Adamichou C, Bergmann C, Sidiropoulos P, Schett G, Fanouriakis A, Boumpas DT, Bertsias G: Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage. RMD Open. 2025;11(3):
Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, Liang M, Rius Rigau A, Zhang Y, Li YN, Dees C, Györfi AH, Wolff D, Herr W, Schett G, Distler JHW, Matei AE: Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD. Blood Adv. 2025;9(6): 1261-1266
Freitag M, Kolb P, Falcone V, Claus M, Schröder P, Andreeva I, Rodon L, Ewald M, Deicher FS, Stütz AN, Distler JHW, Blank N, Grieshaber-Bouyer R, Muñoz LE, Lorenz HM, Schett G, Merkt W: Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapy. Rheumatology (Oxford). 2025;():
Hong X, Xiao Y, Qi H, Zhu S, Filla T, Györfi AH, Li YN, Xu M, Zhi L, Trinh-Minh T, Dees C, Schett G, Distler JHW, Matei AE: Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation. Arthritis Rheumatol. 2025;():
Li YN, Filla T, Györfi AH, Liang M, Devakumar V, Micu A, Chai H, Bergmann C, Pecher AC, Henes J, Moinzadeh P, Al-Gburi S, Krieg T, Kreuter A, Wang J, Schett G, Homey B, Dietrich S, Distler JHW, Matei AE: Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis. Ann Rheum Dis. 2025;84(11): 1852-1864
Gerber JM, Dehdashtian E, Hu G, Gregoire C, Borie D, Bindal P, Cerny J, Geara A, Schett G, Caricchio R: Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis. Lupus Sci Med. 2025;12(2):
Heidinger M, Lang C, Ferrari J, Krebs S, Sykora M, Kleyhons R, Resch H, Karisik A, Dejakum B, Mölgg K, Granna J, Boehme C, Willeit P, Knoflach M, Schett G, Kiechl S, Lang W: The risk of femoral fracture is increased in patients with ischemic stroke and transient ischemic attack-a population-based observational secondary analysis of the Austrian stroke cohort. Int J Stroke. 2025;():
Kragsnaes MS, Gilbert BTP, Sofíudóttir BK, Rooney CM, Hansen SM, Mauro D, Mullish BH, Bergot AS, Mankia KS, Goel N, Bakland G, Johnsen PH, Miguens Blanco J, Li S, Dumas E, Lage-Hansen PR, Wagenaar C, Bakdash G, Robinson M, Kristiansen K, Marchesi JR, Schett G, Zaiss MM, Orlu M, van Schaadenburg D, Scher JU, McGonagle D, Elewaut D, Breban M, Tugwell P, Finckh A, Ciccia F, Kriegel MA, Daien C, Ellingsen T, Christensen R, EULAR Study Group MICMUC , Kragsnaes MS, Gilbert BTP, Rooney CM, Mauro D, Mullish BH, Bergot AS, Mankia KS, Goel N, Bakland G, Johnsen PH, Raanes SS, Blanco JM, Li S, Dumas E, Wagenaar C, Kastbom A, Rodriguez VR, Guggino G, Bakdash G, Robinson M, Kristiansen K, Marchesi JR, Schett G, Zaiss MM, McGonagle D, Schaadenburg DV, Scher JU, Elewaut D, Breban M, Finckh A, Ciccia F, Kriegel MA, Daien C, Ellingsen T: Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2025;15(12):
Hsieh EWY, Chung JB, Amin A, Askanase AD, Bartok B, Brunetta P, Carrasco-Alfonso MJ, Coney C, Cooper JC, Dall'Era M, Delev N, Eldred A, Furie RA, Garces S, Groover K, Harrington M, Hogan JJ, Imperato GH, Jackson M, Jackson SW, Jongco AM, Karis E, Koegel A, König MF, Koretzky G, Kumar V, Morand E, Payne AS, Popat V, Rizvi N, Rohan P, Sadelain M, Schett G, Singh AP, van Vollenhoven RF, Zack D, Lupus ABC CAR T Working Group , Amin A, Askanase AD, Bartok B, Bell S, Bowden A, Bridges L, Brunetta P, Carrasco-Alfonso MJ, Chung J, Coney C, Cooper JC, Dall'Era M, Delev N, Diehl S, Eldred A, Furie RA, Garces S, Graef T, Groover K, Hsieh EY, Hogan J, Imperato G, Jackson M, Jackson S, Jongco AM, Karis E, Kim N, Koch A, Koegel A, Konig MF, Koretzky G, Kumar V, Ma Y, Matzkies F, Morand E, Nguyen H, Panico E, Payne A, Peakman M, Peterson R, Popat V, Rizvi N, Rohan P, Sadelain M, Schett G, Singh AP, Sridharan S, Staeva TP, Vollenhoven RV, Wyse K, Zack D: Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective. RMD Open. 2025;11(4):
Coppers B, Heinrich S, Bayat S, Tascilar K, Kleyer A, Simon D, Minopoulou I, Corte G, Fagni F, Schönau V, Leyendecker S, Schett G, Liphardt AM: Hand Function Impairments Are More Pronounced in Female RA and PsA Patients and also Found in Patients without Concurrent Hand Inflammation. Med Sci Sports Exerc. 2025;():
Salehi F, Bayat S, Schett G, Kleyer A, Altstidl T, Eskofier BM: ExSMART-PreRA: Explainable Survival and Risk Assessment Using Machine Learning for Time Estimation in Preclinical Rheumatoid Arthritis. IEEE J Biomed Health Inform. 2025;29(8): 6017-6028
Pelzl R, Benintende G, Gsottberger F, Scholz JK, Ruebner M, Yao H, Wendland K, Rejeski K, Altmann H, Petkovic S, Mellenthin L, Kübel S, Schmiedeberg M, Klein P, Petrera A, Baur R, Eckstein S, Hoepffner-Grundy S, Röllig C, Subklewe M, Huebner H, Schett G, Mackensen A, Laurenti L, Graw F, Völkl S, Nganou-Makamdop K, Müller F: Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment. Blood. 2025;146(11): 1300-1313
McInnes IB, Coates LC, Mease PJ, Ogdie A, Kavanaugh A, Eder L, Schett G, Kivitz A, McGonagle D, Brennan N, Godwood A, Cullen E, Reich K, Ritchlin CT, Merola JF: Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial. Nat Med. 2025;31(12): 4160-4171
Müller F, Schwingen NR, Hagen M, Scholz JK, Aigner M, Wirsching A, Taubmann J, Kretschmann S, Kharboutli S, Krickau T, Naumann-Bartsch N, Benintende G, Spoerl S, Rothe T, Bruns H, Grieshaber-Bouyer R, Metzler M, Blumenthal DB, Graw F, Schett G, Mackensen A, Völkl S: Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma. Blood. 2025;146(9): 1088-1095
Grötsch B, Bozec A, Schett G: Models of Rheumatoid Arthritis. Methods Mol Biol. 2025;2885(): 345-357
Marzo-Ortega H, McInnes IB, Sharaf M, Zabotti A, Rampakakis E, McGonagle D, Abogamal A, Richette P, Schett G: Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated PsA patients with TNFi-IR: COSMOS post-hoc analysis. Rheumatology (Oxford). 2025;():
Müller F, Atreya R, Völkl S, Aigner M, Kretschmann S, Kharboutli S, Leppkes M, Sitte S, Strobel D, Hartmann A, Mehandru S, Colombel JF, Schett G, Mackensen A, Neurath MF: CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis. N Engl J Med. 2025;393(12): 1239-1241
Georgi GM, Bachmann F, Luther J, Derer A, Heimel P, Tangl S, Kahl-Nieke B, LeBlanc A, Helms J, Schett G, Hirsch C, Gruber R, Amling M, Schinke T, Koehne T, Petersen J: The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton. BMC Oral Health. 2025;25(1):
Karisik A, Dejakum B, Moelgg K, Granna J, Felicetti S, Pechlaner R, Mayer-Suess L, Toell T, Buergi L, Scherer L, Willeit K, Heidinger M, Lang C, Ferrari J, Krebs S, Kleyhons R, Resch H, Willeit J, Seekircher L, Tschiderer L, Willeit P, Sykora M, Schett G, Lang W, Knoflach M, Kiechl S, Boehme C: Incidence, characteristics, and consequences of fractures after acute ischemic stroke and TIA-A prospective cohort study. Int J Stroke. 2025;20(9): 1141-1149
Müller F, Hagen M, Schett G, Mackensen A: [CAR T cells in non-malignant diseases]. Inn Med (Heidelb). 2025;66(8): 810-817
Hegelmaier T, Wolleschak D, Pappa V, Wickel J, Geis C, Miske R, Duscha A, Desel C, Böttcher M, Neyazi A, Faissner S, Motte J, Gold R, Borie D, Schett G, Mougiakakos D, Haghikia A: Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis. Med (N Y). 2025;6(9):
Salehi F, Salin E, Smarr B, Bayat S, Kleyer A, Schett G, Fritsch-Stork R, Eskofier BM: A robust machine learning approach to predicting remission and stratifying risk in rheumatoid arthritis patients treated with bDMARDs. Sci Rep. 2025;15(1):
Hess A, Tascilar K, Schenker HM, Konerth L, Schönau V, Sergeeva M, Kreitz S, Prade J, Strobelt S, Selvakumar M, Kleyer A, Englbrecht M, Hueber AJ, Zaiss MM, Feist E, Burmester GR, Voll RE, Finzel S, Baerwald C, Rösch J, Behrens F, Koehm M, da Silva JAP, Damjanov N, Dörfler A, Schett G, Rech J: Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study. Lancet Rheumatol.. 2025;7(8): e565-e575
Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, Auth J, Wacker J, Eckstein M, Alivernini S, Bozec A, Bergmann C, D'Agostino MA, Munoz L, Rech J, Kihm L, Raimondo MG, Schett G, Grieshaber-Bouyer R: BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease. N Engl J Med. 2025;393(15): 1544-1547
Andreev D, Porschitz P, Weidner D, Song R, Weider M, Schett G, Gölz L, Bozec A: A multidimensional analysis of temporomandibular joint and ankle joint erosion in inflammatory arthritis. Front Immunol. 2025;16():
Heming JN, Margraf A, Najder K, Germena G, Richter M, Cappenberg A, Henke K, Bardel B, Schemmelmann L, Oguama M, Lindental P, Amini W, Sobocik J, Schett G, Krönke G, Block H, Rossaint J, Soehnlein O, Zarbock A: CD45 and CD148 Are Critically Involved in Neutrophil Recruitment and Function During Inflammatory Arthritis in Mice. Cells. 2025;14(15):
Dürholz K, Ehnes L, Linnerbauer M, Schmid E, Danzer H, Hinzpeter-Schmidt M, Lößlein L, Amend L, Frech M, Azizov V, Schälter F, Gessner A, Lucas S, Lesker TR, Taudte RV, Hofmann J, Beyer F, Bootz-Maoz H, Reich Y, Romano H, Mauro D, Beckervordersandforth R, Kragsnaes MS, Ellingsen T, Xiang W, Haghikia A, Akdis CA, Ciccia F, Bäuerle T, Sarter K, Strowig T, Yissachar N, Schett G, Rothhammer V, Zaiss MM: Gut-specific histamine 3 receptor signaling orchestrates microglia-dependent resolution of peripheral inflammation. J Clin Invest. 2025;135(18):
Bartsch V, Habboub B, Standfest K, Ausserwinkler M, Knitza J, Schett G, Hueber AJ: Improving preventive health in inflammatory rheumatic diseases: a randomized controlled trial of an educational video intervention. Rheumatology (Oxford). 2025;64(10): 5420-5427
Schenker H, Kuhlmann L, Kaudewitz D, Schuster B, Semrau S, Schmitter C, Voigt R, Merten R, Geinitz H, Fietkau R, Böltz S, Schett G, Distel LV: Increased Sensitivity to Ionizing Radiation in a Relevant Subset of Patients with Cancer and Systemic Lupus Erythematosus. Cells. 2025;14(8):
Wang Q, Xiao ZX, Zheng X, Wang G, Yang L, Shi L, Xiang N, Wang X, Zha GF, Schett G, Chen Z: In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus. N Engl J Med. 2025;393(15): 1542-1544
Pesch G, Piseddu I, Gaertig J, Kramer N, Kramer R, Schulz TU, Zwiebel M, Ledderose S, Retzlaff J, Eckstein M, Schett G, Kammerbauer C, Schmitt C, Kumbrink J, Erdmann M, Kruis W, Dougan M, Mayerle J, French LE, Vera J, Nordmann TM, Mann M, Klauschen F, Anz D, Heinzerling L: Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor-Induced Colitis Compared with Ulcerative Colitis. Cancer Immunol Res. 2025;13(7): 1053-1069
Schwingen NR, Muller F, Hagen M, Wirsching A, Aigner M, Kretschmann S, Kharboutli S, Scholz J, Benintende G, Taubmann J, Krickau T, Naumann-Bartsch N, Bruns H, Grieshaber-Bouyer R, Graw F, Metzler M, Schett G, Mackensen A, Voelkl S: Distinct inflammatory and immune recovery patterns after CD19-directed CAR T-cell therapy in SLE and B-cell lymphoma Blood. 2025;146 Suppl 1(): 1947-1948
Corte G, Atzinger A, Tascilar K, Temiz A, Mutlu MY, de Sousa RN, Raimondo MG, Ramming A, Bayat S, Sticherling M, Kuwert T, Schmidkonz C, Schett G, Fagni F: SYNOVIAL AND ENTHESIAL FIBROBLAST ACTIVATION DETECTED BY 68GA-FAPI-04-PET/ CT PREDICTS THE DEVELOPMENT OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS AND ARTHRALGIA Ann Rheum Dis. 2025;84 Suppl 1():
Corte G, Tascilar K, Kroker A, Minopoulou I, Kleyer A, Simon D, Schett G, Fagni F: CANNABIS-BASED PRODUCTS FOR PAIN MANAGEMENT IN RHEUMATIC DISEASES: HIGH PATIENT-REPORTED EFFICACY AND OPENNESS TO THERAPY DESPITE LOW PRESCRIPTION RATES IN GERMANY AFTER LEGALIZATION OF NON-MEDICAL CANNABIS Ann Rheum Dis. 2025;84 Suppl 1(): 1815-1816
Hagen M, Mueller F, Wirsching A, Kharboutli S, Spoerl S, Duesing C, Krickau T, Metzler M, Voelkl S, Aigner M, Kretschmann S, Vasova I, Saake M, Schliep S, Kubacki T, Hunzelmann N, Bucci L, Taubmann J, Bergmann C, Gyoerfi AH, Dietrich S, Distler J, Grieshaber-Bouyer R, Mackensen A, Schett G: IMMUNOCLEANSING-ASSOCIATED TOXICITY SYNDROME (ICATS) IN CART-CELL TREATED PATIENTS WITH AUTOIMMUNE DISEASE Ann Rheum Dis. 2025;84 Suppl 1(): 1068-1069
Garantziotis P, Anoshkin K, Hagen M, Wirsching A, Gavin PG, Clarke SLN, Muthas D, Close D, Brohawn PZ, Chamberlain C, Belvisi M, Platt A, Ferrari N, Schett G, Grieshaber-Bouyer R: EFFECTS OF CD19 CAR-T CELL THERAPY ON THET CELL COMPARTMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS Ann Rheum Dis. 2025;84 Suppl 1():
Garantziotis P, Beretta L, Lindblom J, Nikolopoulos D, Grieshaber-Bouyer R, Moysidou GS, Hagen M, Wirsching A, Taubmann J, Bergmann C, Bozec A, Barturen G, Fanouriakis A, Bertsias GK, Schneider M, Boumpas D, Alarcon-Riquelme M, Schett G, Parodis I: DISTINCT MOLECULAR RESPONSES TO CD19 CAR-T CELL THERAPY VERSUS STANDARD PHARMACOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS Ann Rheum Dis. 2025;84 Suppl 1(): 2177-2177
Coppers B, Bartanus V, Heinrich S, Bayat S, Kleyer A, Minopoulou I, Simon D, Corte G, Fagni F, Schoenau V, Schett G, Leyendecker S, Liphardt AM: BIOMECHANICAL INVESTIGATION OF IMPAIRMENTS IN PALM ARCH MOBILITY IN RHEUMATOID AND PSORIATIC ARTHRITIS PATIENTS Ann Rheum Dis. 2025;84 Suppl 1():
Bucci L, Boeltz S, Hagen M, Noethling DM, Rothe T, Tur C, Wirsching A, Auth J, Wacker J, Eckstein M, Alivernini S, Bozec A, Bergmann C, DAgostino MA, Raimondo MG, Schett G, Grieshaber-Bouyer R: SAFETY AND EFFICACY OFT CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE Ann Rheum Dis. 2025;84 Suppl 1():
Bucci L, Rothe T, Anoshkin K, Noethling DM, Goetz AK, Eckstein M, Raimondo MG, Schett G, Grieshaber-Bouyer R: EFFECTS OFT CELL ENGAGERS TREATMENT ON B ANDT CELLS IN AUTOIMMUNE DISEASE Ann Rheum Dis. 2025;84 Suppl 1(): 365-366
Bergmann C, Huang S, Auth J, Wirsching A, Hagen M, Kartalczik HN, Grieshaber-Bouyer R, Mueller F, Mackensen A, Schett G, Khanna D: TRAJECTORIES OF THE EUSTAR AI, ACR CRISS AND REVISED CRISS UPON CD19.CARTTREATMENT IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS Ann Rheum Dis. 2025;84 Suppl 1():
Devakumar V, Li YN, Filla T, Rigau AR, Gyoerfi AH, Tuemerdem BS, Neelagar R, Bergmann C, Liang M, Schett G, Distler J, Matei AE: METABOLIC PHENOTYPING OF SYSTEMIC SCLEROSIS SKIN BY SPATIAL PROTEOMICS Ann Rheum Dis. 2025;84 Suppl 1(): 12-13
Blaskowitz PPV, Koehl N, Liphardt AM, Bouzas C, Coppers B, Petit P, Vuillerme N, Bundle V, Rudolf S, Knitza J, Raimondo MG, Labinsky H, Hatscher L, Wirsching A, Bohr D, Araujo E, Ramming A, Ramming AM, Kreienkamp M, Polacsek-Ernst R, Schett G, Morf H: IMPROVING HEALTH OUTCOMES AND REDUCING HEALTHCARE COSTS THROUGH DIGITAL MOVEMENT THERAPY: A RANDOMIZED TRIAL Ann Rheum Dis. 2025;84 Suppl 1():
Elewaut D, Vandercruyssen R, Devan J, Heggli I, Vlieghe C, Jacques P, Dudli S, Ravichandran K, Ramming A, Schett G, Gracey E: GDF15 mediates inflammation-associated bone loss through a brain-bone axis J Immunol. 2025;214 Suppl _1(): 659-659
Ramiro S, Schett G, Marzo-Ortega H, Schmidt WA: The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects. Rheumatol Ther. 2025;12(3): 435-451
Salehi F, Zarifi S, Bayat S, Habibpour M, Asemanrafat A, Kleyer A, Schett G, Fritsch-Stork R, Eskofier BM: Predicting Disease Activity Score in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs Using Machine Learning Models Technologies. 2025;13(8):
Bayat S, Atzinger A, Tascilar K, Kleyer A, Hueber A, Fagni F, Corte G, Schett G: FIBROBLAST ACTIVATION DETECTED BY FAPI-PET/ CT AS A SIGN OF IMPENDING RA Ann Rheum Dis. 2025;84 Suppl 1():
McInnes IB, Eder L, Ritchlin CT, Ogdie A, Kavanaugh A, Coates LC, Schett G, Kivitz A, Brennan N, Godwood A, Thomas MR, Cullen E, Reich K, Merola JF, Mease PJ: IMPACT OF SONELOKIMAB, A NOVEL IL-17A-AND IL-17F-INHIBITING NANOBODY, ON MULTIDOMAIN CLINICAL OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 ARGO TRIAL Ann Rheum Dis. 2025;84 Suppl 1():
Hagen M, Wirsching A, Mueller F, Kharboutli S, Bergmann C, Boeltz S, Taubmann J, Tur C, Bucci L, Voelkl S, Aigner M, Kretschmann S, Spoerl S, Vasova I, Aletaha D, Kiener H, Natalello G, Locatelli F, D'Agostino MA, Bozec A, Hanssens L, Grieshaber-Bouyer R, Mackensen A, Schett G: SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR T-CELL TREATMENT IN RHEUMATIC DISEASE-DATA FROM THE PHASE I/II CASTLE BASKET STUDY Ann Rheum Dis. 2025;84 Suppl 1():
Bucci L, Rothe T, Mueller F, Taubmann J, Hagen M, Bergmann C, Tur C, Munoz L, Wilhelm A, Gerlach R, Schaefer S, Voelkl S, Aigner M, Grieshaber-Bouyer R, Kroenke G, Bozec A, Winkler T, Mackensen A, Schett G: EFFECTS OF CAR-T CELL TREATMENT ON B CELL IMMUNITY IN SYSTEMIC AUTOIMMUNE DISEASES Ann Rheum Dis. 2025;83 Suppl 1():
Grieshaber-Bouyer R, Garantziotis P, Ostendorf L, Schoen J, Schett G, Rao D: NEUTROPHIL-DERIVED LAMP1 IS ASSOCIATED WITH PROLIFERATIVE LUPUS NEPHRITIS Ann Rheum Dis. 2025;83 Suppl 1():
Temiz A, Mutlu MY, Corte G, Simon D, Rech J, Werner D, Tascilar K, Fagni F, Schett G, Kleyer A: EFFECT OF ABATACEPT ON EROSIVE PSORIATIC ARTHRITIS-RESULTS FROM A PROSPECTIVE INTERVENTIONAL TRIAL (ABEPSA) Ann Rheum Dis. 2025;84 Suppl 1():
Loy N, Blazek V, Jukic E, Fleischmann E, Coppers B, Huebner J, Iqbal M, Heinrich S, Scheiterer E, Leyendecker S, Greenfield J, Labinski H, Raimondo MG, Ramming A, Schoenau V, Schett G, Knitza J, Liphardt AM: FEAR OF MOVEMENT AFFECTS RANGE OF MOTION DURING REPEATED BASMI EXERCISES ASSESSED BY STATE-OF-THE-ART MOTION CAPTURE TECHNIQUES Ann Rheum Dis. 2025;83 Suppl 1():
Regierer A, Weiss A, Behrens F, Worsch M, Pagel K, Schett G, Strangfeld A: DRUG RETENTION RATE OFTNFi BIO-ORIGINALS AND BIOSIMILARS IN axSpA AND PsA IN ROUTINE RHEUMATOLOGY CARE IN GERMANY Ann Rheum Dis. 2025;83 Suppl 1():
Li YN, Filla T, Gyoerfi AH, Liang M, Devakumar V, Micu A, Chai H, Bergmann C, Pecher AC, Henes J, Moinzadeh P, Al-Gburi S, Krieg T, Kreuter A, Wang J, Schett G, Homey B, Dietrich S, Distler J, Matei AE: IDENTIFICATION OF FIBROBLAST POPULATIONS AND THEIR PATHOGENIC NICHES IN SYSTEMIC SCLEROSIS BY IMAGING-BASED SPATIAL TRANSCRIPTOMICS Ann Rheum Dis. 2025;84 Suppl 1():
Maeda Y, Wirtz S, Hagen M, Rothe T, Wirsching A, Grieshaber-Bouyer R, Gimaev I, Schmid E, Kriegel M, Mueller F, Mackensen A, Schett G, Zaiss MM: ALTERED GUT MICROBIOTA COMPOSITION IN AUTOIMMUNE DISEASE PATIENTS UNDERGOING CD19-CAR T-CELL THERAPY Ann Rheum Dis. 2025;84 Suppl 1():
Tascilar K, Ostergaard M, Schoenau V, Kiltz U, Baraliakos X, Fleck M, Kofler DM, Feuchtenberger M, Steffen (nee Harre) U, Zaiss MM, Zaenker M, Voll R, Glaser C, Feist E, Burmester GR, Zernicke J, Koehm M, Behrens F, Karberg K, Strunk J, Crespillo JDDC, Naredo E, Filkova M, Senolt L, Schett G, Rech J: LONG-TERM PREVENTION OF RA IN HIGH-RISK INDIVIDUALS AFTER A 6-MONTH PLACEBO-CONTROLLED INTERVENTION WITH ABATACEPT-THE ARIAA TRIAL Ann Rheum Dis. 2025;84 Suppl 1():
Taubmann J, Hagen M, Mueller F, Wirsching A, Temiz A, Voelkl S, Aigner M, Grieshaber-Bouyer R, Mackensen A, Schett G: EFFECTS OF CD19 CART-CELL THERAPY ON QUALITY OF LIFE AND DIRECT HEALTH CARE COSTS IN SYSTEMIC LUPUS ERYTHEMATOSUS Ann Rheum Dis. 2025;84 Suppl 1():
Khanna D, Wiesendanger M, Nash R, Mease PJ, Askanase A, Bernstein E, Kramer N, Majithia V, Azzi J, Korman D, Patel K, Schwede MH, Reshef R, Ayala E, Desai A, McTume G, Das S, Thorpe J, Stifano G, Koegel A, Schett G: TOLERABILITY AND EFFICACY OF BMS-986353 (CC-97540), A CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR)T CELL THERAPY MANUFACTURED USING A NEXT-GENERATION PROCESS FOR SYSTEMIC SCLEROSIS: UPDATED DATA FROM THE PHASE 1 BREAKFREE-1 STUDY Ann Rheum Dis. 2025;84 Suppl 1():
Schlereth M, de Sousa RN, Corte G, Tur C, Minopoulou I, Mutlu MY, Temiz A, Bayat S, Simon D, Schett G, Kleyer A, Breininger K, Fagni F: DEVELOPMENT OFA DEEP LEARNING-BASED TOOL FOR THE AUTOMATED GRADING OF SYNOVITIS AND CLASSIFICATION OF ARTHRITIS USING ULTRASOUND IMAGING Ann Rheum Dis. 2025;84 Suppl 1():
Stuetz A, De Luca G, Matei AE, Li YN, Batani V, Filla T, Rigau AR, Tuemerdem BS, Bruni DC, Eckstein M, Schett G, Basso C, Distle J, Matucci-Cerinic M, Gyoerfi AH: SPATIAL PROTEOMIC-BASED PHENOTYPING OF FIBROBLAST SUBPOPULATIONS AND THEIR MICROENVIRONMENT IN SYSTEMIC SCLEROSIS PRIMARY HEART INVOLVEMENT Ann Rheum Dis. 2025;84 Suppl 1():
Temiz A, Schuster L, Mutlu MY, Tascilar K, Bayat S, Rech J, Hueber A, Kleyer A, Simon D, Schett G, Fagni F: SECUKINUMAB DEMONSTRATES HIGH LONG-TERM EFFICACY, DRUG SURVIVAL, AND OSTEOPROTECTIVE EFFECTS IN PSORIATIC ARTHRITIS AND PSORIASIS: 48-MONTH FOLLOW-UP OF THE PSARTROS STUDY Ann Rheum Dis. 2025;84 Suppl 1():
Tragl S, Manger E, Niemiec L, Coppers B, Bayat S, Kleyer A, Simon D, Tascilar K, Rech J, Schett G, Hueber A, Liphardt AM: BONE MORPHOLOGY IS RELATED WITH HAND FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS Ann Rheum Dis. 2025;84 Suppl 1():
Dees C, Kalyva A, Bergmann C, Kunz M, Schett G, Distler J: ACTIVATION OF NOTCH1 SIGNALING IN FIBROBLASTS IS SUFFICIENT TO INDUCE FIBROSIS AND ACTIVATES A NETWORK OF PROFIBROTIC SIGNALING CASCADES Ann Rheum Dis. 2025;83 Suppl 1():
Garantziotis P, Beretta L, Lindblom J, Nikolopoulos D, Bertsias G, Hagen M, Taubmann J, Wirsching A, Bozec A, Grieshaber-Bouyer R, Schneider M, Barturen G, Boumpas D, Alarcon-Riquelme M, Schett G, Parodis I, PRECISESADS CLIN CONSORTIUM: DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS J Rheumatol. 2025;52 Suppl 1(): 8-8
Mauro D, Vecellio M, Schmid E, Bergot AS, Forte G, Stingo A, Salzillo A, Pastore A, Aretini P, Ciancio A, Pantano I, Saccone G, Zullo F, Montecucco C, Rizzo A, Schett G, Thomas R, Zaiss MM, Ciccia F: CROSSING THE BARRIERS: DYSBIOSIS AND SUBCLINICAL UTERINE INFLAMMATION IN THE PATHOGENESIS OF AxSpA IN FEMALES. ANOTHER BREAK IN THE WALL? Ann Rheum Dis. 2025;83 Suppl 1():
Mueller F, Schwingen NR, Hagen M, Scholz J, Aigner M, Wirsching A, Taubmann J, Kretschmann S, Kharboutli S, Krickau T, Naumann-Bartsch N, Benintend G, Spoerl S, Roth T, Bruns H, Grieshaber-Bouye R, Metzler M, Blumenthal DB, Graw F, Schett G, Mackensen A, Voelkl S: Comparison of the safety profle of CD19-targeting CAR T-cell therapy in patients with refractory systemic lupus erythematosus and B-cell lymphoma Oncology Research and Treatment. 2025;48 Suppl 2(SUPPL 2):
Noethling DM, Bucci L, Rothe T, Anoshkin K, Hagen M, Wirsching A, Taubmann J, Garantziotis P, Voelkl S, Mueller F, Mackensen A, Schett G, Grieshaber-Bouyer R: B CELL RECONSTITUTION IN SLE PATIENTS AFTER CAR-T CELL THERAPY IS MARKED BY A NAÏVE PHENOTYPE AND REDUCTION OF EXTRAFOLLICULAR IMMUNE RESPONSES Ann Rheum Dis. 2025;84 Suppl 1():
Minopoulou I, Wilhelm A, Albach FN, Kleyer A, Wiebe E, Fleischmann A, Frick M, Damm F, Borie D, Casteleyn V, Biesen R, Doerner T, Alexander T, Zernicke J, Hinkelmann L, Phitak E, Drzeniek NM, Movassaghi K, Huetter-Kroenke ML, Schrezenmeier E, Schreiber A, Schneider U, Schett G, Bullinger L, Kroenke G, Penack O, Simon D: EFFECT OF ANTI-CD19 CART CELLTHERAPY IN THE BONE MARROW OF PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES Ann Rheum Dis. 2025;84 Suppl 1():
Hess A, Tascilar K, Schett G, Rech J: From whole-brain metrics to circuit-specific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis - Authors' reply. Lancet Rheumatol.. 2025;7(11):
Peng J, Zhang Y, Wang J, Zhang H, Schett G: Role of Chimeric Antigen Receptor-Expressing Cell Therapy in Immune-Mediated Kidney Diseases: A Review. Am J Kidney Dis. 2025;86(3): 360-371
Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, Angeli MR, Fagni F, Corte G, Tascilar K, Labinsky H, Ramming AM, Roemer F, Rech J, Braeuer L, D'Agostino MA, Schett G, Pachowsky M, Kleyer A, Ramming A: Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. Ann Rheum Dis. 2025;():
Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, Nöthling DM, Böltz S, Wirsching A, Tascilar K, Fagni F, Corte G, Rius Rigau A, Qin Y, Garantziotis P, Taubmann J, Wacker J, Ramming A, D Agostino MA, Rauch S, Hartmann A, Müller F, Mackensen A, Grieshaber-Bouyer R, Schett G, Bozec A, Raimondo MG: Effects of different B-cell-depleting strategies on the lymphatic tissue. Ann Rheum Dis. 2025;84(12): 2065-2074
Temiz A, Tascilar K, Kleyer A, Hueber AJ, Hartmann F, Schett G, Bayat S: Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a real-world prospective cohort study. RMD Open. 2025;11(4):
Taubmann J, Böltz S, Hagen M, Wirsching A, Müller F, Völkl S, Kharboutli S, Spörl S, Garantziotis P, Aigner M, Grieshaber-Bouyer R, Mackensen A, Schett G: [Long-term follow up of efficiency and safety of CD19-CAR T-cell treatment of systemic lupus erythematosus]. Z Rheumatol. 2025;84(8): 612-620
Bartsch V, Habboub B, Standfest K, Ausserwinkler M, Knitza J, Schett G, Hueber AJ: Does an Educational Video Improve Adherence to Preventive Health Measures in Rheumatic Diseases? Results from the KOMO-R Randomized Controlled Trial Inn Med (Heidelb). 2025;66 Suppl 1(): S159-S160
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, Bae SS, Lim D, Rivero-Gallegos D, Yamano Y, Selva-O'Callaghan A, Mammen AL, Scirè CA, Montecucco C, Oddis CV, Fiorentino D, Bonella F, Miller FW, Lundberg IE, Schmidt J, Rojas-Serrano J, Hudson M, Kuwana M, González-Gay MA, McHugh N, Corte TJ, Doyle TJ, Werth VP, Gupta L, Perez Roman DI, Bianchessi LM, Devarasetti PK, Shinjo SK, Luppi F, Cavazzana I, Moghadam-Kia S, Fornaro M, Volkmann ER, Piga M, Loarce-Martos J, De Luca G, Knitza J, Wolff-Cecchi V, Sebastiani M, Schiffenbauer A, Rider LG, Campanilho-Marques R, Marts L, Bravi E, Gunawardena H, Aggarwal R, Cavagna L, Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators , Anuja A, Sambataro D, Colaci M, Vancheri C, Mejia M, Rivera Matias PA, Bottazzi F, Alpini C, Rajasekhar L, Agarwal V, De Souza FHC, Miossi R, Pozzi MR, Faverio P, Franco G, Dei G, Franceschini F, Lacomis D, Iannone F, Girolamo F, Trallero-Araguás E, Gil-Vila A, Villar A, Charles-Schoeman C, Bukiri H, Murru C, Cauli A, Bachiller-Corral J, Dagna L, Campochiaro C, Distler J, Schett G, Florenzano M, Reyes F, Amato A, Dellaripa P, Saavedra S, Vergara K, Manfredi A, Vacchi C, Melo T, Gandiga P, Amratia D, Arrigoni E, Kaneko Y, Triantafyllias K, Mandel A, Castañeda S, Vicente-Rabaneda EF, Landon-Cardinal O, Alberti ML, Caro F, Greco Merino MG, Rua-Figueroa I, Fiehn C, Bauhammer J, Molad Y, Klein O, Govoni M, Nakashima R, Alpsoy E, Meyer A, Giannini M, Chinoy H, Lilleker J, Gallay L, Cottin V, Dieudè P, Campagne J, Saraiva AP, Conticini E, Sebastiani G, Nuno L, Scarpato S, Schiopu E, Sainaghi PP, Jovani V, Barsotti S, Umezawa N, Needham M, Cagnotto G, Danieli MG, Tomietto P, Gomez NP, Limonta M, Barausse G, Kondo Y, Ghetie D, Tamirou F, Basharat P, Tomaras S, Voll RE, Andersson H, Barrio JM, Schneider M, Parronchi P, Notarnicola A, Cifrian J: Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. Arthritis Rheumatol. 2025;77(4): 477-489
Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, Register A, Heesen C, Kröger N, Schett G, Mackensen A, Podoll A, Gutman J, Furie R, Bayer R, Distler JHW, Dietrich S, Krönke G, Bullinger L, Walker K: Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders. Cytotherapy. 2025;27(2): 236-246
Chenguiti Fakhouri S, Zhu H, Li YN, Ronicke M, Rigau AR, Dees C, Konstantinidis L, Schmid R, Matei AE, Eckstein M, Geppert C, Ludolph I, Kreuter A, Sticherling M, Berking C, Horch RE, Schett G, Distler JHW, Bergmann C: Disturbed Spatial WNT Activation-A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis. Arthritis Rheumatol. 2025;77(6): 740-749

Publications: Prof. Dr. med. univ. G. Schett

Emergency

Emergencies UKER

Patients & Visitors

Doctors & referring physicians

Research

Teaching